Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 16.245 USD -0.64% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Neogenomics Inc
Accrued Liabilities Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Accrued Liabilities
$78.9m
CAGR 3-Years
11%
CAGR 5-Years
16%
CAGR 10-Years
33%
Thermo Fisher Scientific Inc
NYSE:TMO
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Danaher Corp
NYSE:DHR
Accrued Liabilities
$2.9B
CAGR 3-Years
-4%
CAGR 5-Years
4%
CAGR 10-Years
1%
Mettler-Toledo International Inc
NYSE:MTD
Accrued Liabilities
$338.3m
CAGR 3-Years
-2%
CAGR 5-Years
3%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Accrued Liabilities
$573m
CAGR 3-Years
-8%
CAGR 5-Years
5%
CAGR 10-Years
-2%
IQVIA Holdings Inc
NYSE:IQV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Neogenomics Inc's Accrued Liabilities?
Accrued Liabilities
78.9m USD

Based on the financial report for Sep 30, 2024, Neogenomics Inc's Accrued Liabilities amounts to 78.9m USD.

What is Neogenomics Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
33%

Over the last year, the Accrued Liabilities growth was 9%. The average annual Accrued Liabilities growth rates for Neogenomics Inc have been 11% over the past three years , 16% over the past five years , and 33% over the past ten years .

Back to Top